Interferons α and β in cancer: therapeutic opportunities from new insights
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/s41573-018-0011-2.pdf
Reference259 articles.
1. Borden, E. C. et al. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975–990 (2007). This review encompasses the underlying cellular effects of interferons for inhibition of cancer, viral infections and multiple sclerosis.
2. Gresser, I., Bourali, C., Levy, J. P., Fontaine-Brouty-Boye, D. & Thomas, M. T. Increased survival in mice inoculated with tumor cells and treated with interferon preparations. Proc. Natl Acad. Sci. USA 63, 51–57 (1969).
3. Borden, E. C. Interferons: rationale for clinical trials in neoplastic disease. Ann. Intern. Med. 91, 472–479 (1979).
4. Strander, H., Cantell, K., Carlstrom, G. & Jakobsson, P. A. Clinical & laboratory investigations on man: systemic administration of potent interferon to man. J. Natl Cancer Inst. 51, 733–742 (1973).
5. Gutterman, J. U. et al. Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann. Intern. Med. 93, 399–406 (1980).
Cited by 294 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer;Computational and Structural Biotechnology Journal;2024-12
2. Co-expression of human sialyltransferase improves N-glycosylation in Leishmania tarentolae and optimizes the production of humanized therapeutic glycoprotein IFN-beta;Journal of Biotechnology;2024-11
3. A Photoactivatable Self-Assembled Nanoagonist for Synergistic Therapy against Pancreatic Ductal Adenocarcinoma;Nano Letters;2024-09-09
4. USP24 is an ISG15 cross-reactive deubiquitinase that mediates IFN-I production by de-ISGylating the RNA helicase MOV10;2024-09-06
5. Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-β signaling pathways;Biomedicine & Pharmacotherapy;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3